The proposed rationale is that cancer cells with a dysfunctional p53, a key component of the G1/S DNA-damage checkpoint, are more dependent on G2/M checkpoint to repair DNA damages (Matheson et al., 2016). The gene discussed is TP53; the disease is cancer.